^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

DNAH17 (Dynein Axonemal Heavy Chain 17)

i
Other names: DNAH17, Dynein Axonemal Heavy Chain 17, DNEL2, DNAHL1, Axonemal Dynein Heavy Chain-Like Protein 1, Ciliary Dynein Heavy Chain-Like Protein 1, Dynein, Axonemal, Heavy Polypeptide 17, Axonemal Beta Dynein Heavy Chain 17, Ciliary Dynein Heavy Chain 17, Dynein Axonemal Light Chain 2, FLJ40457, Dynein, Axonemal, Heavy Chain Like 1, Dynein Heavy Chain 17, Axonemal, Dynein, Axonemal, Heavy Like 1, Dynein Light Chain 2, Axonemal, SPGF39
Associations
Trials
2ms
Synolitic Graph Neural Networks of High-Dimensional Proteomic Data Enhance Early Detection of Ovarian Cancer. (PubMed, Cancers (Basel))
These results highlight the potential of network-informed machine learning to identify subtle proteomic patterns and pathway-level dysregulation prior to clinical diagnosis. This proof-of-concept study supports further development of GNN approaches for early ovarian cancer detection and warrants validation in larger, independent cohorts.
Journal
|
CHI3L1 (Chitinase 3-like 1) • AGR2 (Anterior gradient 2) • FSTL1 (Follistatin Like 1) • DNAH17 (Dynein Axonemal Heavy Chain 17)
5ms
Antisense RNAs (asRNAs) as key players in gallbladder cancer progression: a bioinformatics analysis. (PubMed, Gastroenterol Hepatol Bed Bench)
Enrichment analysis of asRNAs with target mRNAs showed enrichment in biological regulation and developmental processes involved in the PI3K, p53, apoptosis, and VEGF signaling pathways. This study identified 14 asRNAs for the first time and showed that asRNAs targeting mRNAs strongly associated with tumor development in GBC through the PI3KCA and TP53 pathways.
Journal
|
BBOX1 (Gamma-Butyrobetaine Hydroxylase 1) • BBOX1-AS1( BBOX1 Antisense RNA 1) • HAND2-AS1 (HAND2 Antisense RNA 1) • MIR1-1 (MicroRNA 1-1) • SLC2A1 (Solute Carrier Family 2 Member 1) • SOX21-AS1 (SOX21 Antisense Divergent Transcript 1) • DNAH17 (Dynein Axonemal Heavy Chain 17)
over1year
LncRNA DNAH17-AS1 promotes gastric cancer proliferation and radioresistance by sponging miR-202-3p to upregulate ONECUT2. (PubMed, Discov Oncol)
In addition, the DNAH17-AS1/miR-202-3p/ONECUT2 axis promoted the radioresistance of GC. In summary, DNAH17-AS1 plays crucial roles in GC progression and may be a novel promising target for therapy.
Journal
|
ONECUT2 (One Cut Homeobox 2) • DNAH17 (Dynein Axonemal Heavy Chain 17)
over1year
Is cross-species horizontal gene transfer responsible for gallbladder carcinogenesis. (PubMed, World J Surg Oncol)
The results provide novel evidence supporting the hypothesis that differentially expressed asRNAs in GBC exhibit varying sequence similarity with bacterial, viral, and ancient human genomes, indicating a potential shared evolutionary origin. These non-coding genes are enriched with methylation and were found to be associated with cancer-related pathways, including the P53 and PI3K-AKT signaling pathways, suggesting their possible involvement in tumor development.
Journal
|
BBOX1 (Gamma-Butyrobetaine Hydroxylase 1) • AFAP1-AS1 (AFAP1 Antisense RNA 1) • HMGA2 (High mobility group AT-hook 2) • BBOX1-AS1( BBOX1 Antisense RNA 1) • HAND2-AS1 (HAND2 Antisense RNA 1) • MIR1-1 (MicroRNA 1-1) • SLC2A1 (Solute Carrier Family 2 Member 1) • SOX21-AS1 (SOX21 Antisense Divergent Transcript 1) • DNAH17 (Dynein Axonemal Heavy Chain 17)
over2years
Expression of cAMP and oxidative phosphorylation-related lncRNAs in non-functioning pituitary adenomas. (PubMed, J Cell Mol Med)
The level of SLC25A5-AS1 was lower in subjects with disease duration lower than 1 year (p-value = 0.048). We showed dysregulation of three lncRNAs in NFPA tissues and potentiates these lncRNAs as important regulators of pathogenic events in these tumours.
Journal
|
MIR7 (MicroRNA 7) • DNAH17 (Dynein Axonemal Heavy Chain 17)
over2years
Impact of Genomic Alterations on the Clinical Outcome of Patients With Hepatitis B-related Hepatocellular Carcinoma Receiving Curative Surgery: A Retrospective Cohort Study. (PubMed, Anticancer Res)
Our results present an in-depth genomic analysis of HBV-related HCC. The study findings provide an improved understanding of the related molecular mechanisms and identify potential biomarkers associated with early tumour recurrence after curative resection.
Clinical data • Retrospective data • Journal • Tumor mutational burden • MSi-H Biomarker • Surgery
|
TP53 (Tumor protein P53) • TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • MUC16 (Mucin 16, Cell Surface Associated) • TTN (Titin) • ITGA4 (Integrin, alpha 4) • RPS6KA3 (Ribosomal Protein S6 Kinase A3) • SYNE1 (Spectrin Repeat Containing Nuclear Envelope Protein 1) • PCLO (Piccolo Presynaptic Cytomatrix Protein) • DNAH17 (Dynein Axonemal Heavy Chain 17)
|
TP53 mutation • MSI-H/dMMR
over2years
Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy. (PubMed, Discov Oncol)
From perspective of SASP, we found detrimental and beneficial tumor subtypes which were closely associated with BCR-free survival for PCa patients, which might be important for the furture research in the field of PCa.
Journal • Tumor mutational burden
|
TMB (Tumor Mutational Burden) • MSI (Microsatellite instability) • HRD (Homologous Recombination Deficiency) • CD8 (cluster of differentiation 8) • KMT2C (Lysine Methyltransferase 2C) • SPOP (Speckle Type BTB/POZ Protein) • FOXA1 (Forkhead Box A1) • IGFBP3 (Insulin-like growth factor binding protein 3) • EPPK1 (Epiplakin 1) • ZKSCAN1 (Zinc Finger With KRAB And SCAN Domains 1) • DNAH17 (Dynein Axonemal Heavy Chain 17) • ZC3H13 (Zinc Finger CCCH-Type Containing 13)
|
HRD